NFE2L1
Basic information
Region (hg38): 17:48048329-48061545
Previous symbols: [ "TCF11" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFE2L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 62 | 63 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 63 | 1 | 1 |
Variants in NFE2L1
This is a list of pathogenic ClinVar variants found in the NFE2L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-48051155-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
17-48051227-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
17-48051228-C-T | not specified | Uncertain significance (Nov 23, 2021) | ||
17-48051265-C-T | Benign (Jul 13, 2018) | |||
17-48051304-G-T | not specified | Uncertain significance (Jun 07, 2024) | ||
17-48051315-G-T | not specified | Uncertain significance (Jun 07, 2023) | ||
17-48051321-A-G | not specified | Uncertain significance (Oct 17, 2024) | ||
17-48051345-A-G | not specified | Uncertain significance (Nov 24, 2024) | ||
17-48051359-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
17-48051360-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
17-48051362-C-T | not specified | Uncertain significance (Feb 02, 2022) | ||
17-48051363-G-A | not specified | Uncertain significance (Jul 09, 2024) | ||
17-48051534-G-C | not specified | Uncertain significance (Dec 22, 2024) | ||
17-48051536-G-C | not specified | Uncertain significance (Jan 23, 2023) | ||
17-48051537-T-C | not specified | Uncertain significance (Dec 17, 2023) | ||
17-48051539-C-T | Uncertain significance (Jul 14, 2022) | |||
17-48051566-G-T | not specified | Uncertain significance (Feb 08, 2025) | ||
17-48051572-G-T | not specified | Uncertain significance (Sep 08, 2024) | ||
17-48056440-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
17-48056456-A-G | not specified | Uncertain significance (Jun 11, 2021) | ||
17-48056464-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
17-48056465-G-A | not specified | Uncertain significance (Apr 28, 2023) | ||
17-48056498-G-A | not specified | Likely benign (Jun 02, 2023) | ||
17-48056507-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
17-48056509-G-A | not specified | Uncertain significance (Nov 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NFE2L1 | protein_coding | protein_coding | ENST00000362042 | 5 | 13159 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00241 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.76 | 343 | 447 | 0.766 | 0.0000271 | 5026 |
Missense in Polyphen | 100 | 175.06 | 0.57125 | 1946 | ||
Synonymous | -0.116 | 192 | 190 | 1.01 | 0.0000112 | 1624 |
Loss of Function | 4.65 | 3 | 30.9 | 0.0971 | 0.00000217 | 283 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000619 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Endoplasmic reticulum membrane sensor NFE2L1: Endoplasmic reticulum membrane sensor that translocates into the nucleus in response to various stresses to act as a transcription factor (PubMed:20932482, PubMed:24448410). Constitutes a precursor of the transcription factor NRF1 (By similarity). Able to detect various cellular stresses, such as cholesterol excess, oxidative stress or proteasome inhibition (PubMed:20932482). In response to stress, it is released from the endoplasmic reticulum membrane following cleavage by the protease DDI2 and translocates into the nucleus to form the transcription factor NRF1 (By similarity). Acts as a key sensor of cholesterol excess: in excess cholesterol conditions, the endoplasmic reticulum membrane form of the protein directly binds cholesterol via its CRAC motif, preventing cleavage and release of the transcription factor NRF1, thereby allowing expression of genes promoting cholesterol removal, such as CD36 (By similarity). Involved in proteasome homeostasis: in response to proteasome inhibition, it is released from the endoplasmic reticulum membrane, translocates to the nucleus and activates expression of genes encoding proteasome subunits (PubMed:20932482). {ECO:0000250|UniProtKB:Q61985, ECO:0000269|PubMed:20932482, ECO:0000269|PubMed:24448410}.;
Recessive Scores
- pRec
- 0.160
Intolerance Scores
- loftool
- 0.105
- rvis_EVS
- -1.46
- rvis_percentile_EVS
- 3.78
Haploinsufficiency Scores
- pHI
- 0.735
- hipred
- Y
- hipred_score
- 0.775
- ghis
- 0.621
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.969
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nfe2l1
- Phenotype
- immune system phenotype; liver/biliary system phenotype; embryo phenotype; neoplasm; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- nfe2l1b
- Affected structure
- anatomical structure
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- transcription by RNA polymerase II;heme biosynthetic process;inflammatory response;cholesterol metabolic process;anatomical structure morphogenesis;erythrocyte differentiation;cellular response to oxidative stress;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;integral component of membrane;protein-containing complex
- Molecular function
- transcription regulatory region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription coregulator activity;protein binding;lipid binding;protein domain specific binding;protein-containing complex binding